CLINICAL_TRIALS
trial_result
· 2017-07-25
Clinical Trial Update: A Study in Participants With Moderate to Severe Psoriasis [Phase 2]
Summary
Phase 2 study in participants with moderate to severe psoriasis completed; results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2017-07-25